D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
RIGL holding history
Rigel Pharmaceuticals Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RIGL overviewAll 13F holders of RIGLFull Q2 2026 holdings
- Shares (Q2 2026)
- 542,539
- Value
- $21.2M
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 542,539 | $21.2M | <0.1% | +96,861+21.7% | Added | Holders |
| Q1 2026 | 445,678 | $12.1M | <0.1% | +21,362+5.0% | Added | Holders |
| Q4 2025 | 424,316 | $18.2M | <0.1% | +117,827+38.4% | Added | Holders |
| Q3 2025 | 306,489 | $8.68M | <0.1% | +306,489 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −3,352,899−100.0% | Sold out | Holders |
| Q4 2022 | 3,352,899 | $5.03M | <0.1% | −1,293,565−27.8% | Reduced | Holders |
| Q3 2022 | 4,646,464 | $5.48M | <0.1% | +1,171,928+33.7% | Added | Holders |
| Q2 2022 | 3,474,536 | $3.93M | <0.1% | +2,940,803+551.0% | Added | Holders |
| Q1 2022 | 533,733 | $1.60M | <0.1% | +451,446+548.6% | Added | Holders |
| Q4 2021 | 82,287 | $218.0K | <0.1% | −46,661−36.2% | Reduced | Holders |
| Q3 2021 | 128,948 | $468.0K | <0.1% | +128,948 | New | Holders |